Consistent therapeutic efficacy of CH5424802/RO5424802 in brain metastases among crizotinib-refractory ALK-positive non-small cell lung cancer (NSCLC) patients in an ongoing phase I/II study (AF-002JG/NP28761, NCT01588028) Meeting Abstract
| Authors: | Ou, S. H. I.; Gadgeel, S.; Chiappori, A. A.; Gandhi, L.; Azada, M.; Garcia, L.; Takaya, I.; Yokoyama, S.; Kamei, T.; Tanaka, T.; Lee, R. M.; Riely, G. |
| Abstract Title: | Consistent therapeutic efficacy of CH5424802/RO5424802 in brain metastases among crizotinib-refractory ALK-positive non-small cell lung cancer (NSCLC) patients in an ongoing phase I/II study (AF-002JG/NP28761, NCT01588028) |
| Meeting Title: | 15th World Conference on Lung Cancer (IASLC) |
| Keywords: | efficacy; cns metastasis; alk-inhibitor; ch5424802/ro5424802 |
| Journal Title: | Journal of Thoracic Oncology |
| Volume: | 8 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2013 Oct 27-31 |
| Meeting Location: | Sydney, Australia |
| ISSN: | 1556-0864 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2013-11-01 |
| Start Page: | S200 |
| Language: | English |
| ACCESSION: | WOS:000339624900248 |
| PROVIDER: | wos |
| DOI: | 10.1097/01.JTO.0000438438.14562.c8 |
| Notes: | Meeting Abstract: O16.07 -- Source: Wos |
